Laboratorios Alpharma, S.A. de C.V.

Alpharma belongs to a group that is oriented to the construction of an efficient set of business units that seek to innovate, develop, produce, commercialize and distribute medicines and services, based on human capital, the support of advanced technology and a network of highly competitive external supports.

Alpharma has the OTC line, a line of generics and the Cardio-Metabolic and Musculoskeletal Health divisions.

The product portfolio is supported by considerable investment in research and bioequivalence studies, as well as by numerous relationships with public health institutes such as the National Cancer Institute (INCan), the National Institute of Neurology and Neurosurgery (INNN), the Children's Hospital, as well as Research Centers of the National Autonomous University of Mexico (UNAM), the Metropolitan Autonomous University (UAM) and the Center for Research and Advanced Studies (Cinvestav).

In these almost 50 years, Alpharma, a proudly Mexican company, reaffirms its commitment to the health of Mexicans and consolidates itself as the laboratory with the widest and most complete line; with the constant validation of its components to offer better therapeutic alternatives, adding drugs of excellence that allow greater solutions for health, with the purpose of providing comprehensive pharmacological care that contributes to the well-being and better quality of life of patients.